Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.640
-0.120 (-3.19%)
Mar 6, 2026, 10:45 AM EST - Market open
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $56.33 million as of March 6, 2026. Its market cap has increased by 66.15% in one year.
Market Cap
56.33M
Enterprise Value
39.51M
1-Year Change
66.15%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $56.33M, a decrease of -99.17%. That is a compound annual growth rate of -34.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 58.20M | 19.02% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 63.33M |
| InflaRx | 62.02M |
| NeurAxis | 61.89M |
| Spruce Biosciences | 61.59M |
| TScan Therapeutics | 61.29M |
| Metagenomi Therapeutics | 60.07M |
| Entera Bio | 59.61M |
| NRx Pharmaceuticals | 59.60M |